Connor, Clark & Lunn Investment Management (CC&L)’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $980K | Buy |
|
|||||
|
2021
Q3 | $1.61M | Buy |
|
|||||
|
2021
Q2 | $67K | Sell |
|
|||||
|
2021
Q1 | $676K | Sell |
|
|||||
|
2020
Q4 | $1.76M | Buy |
|
|||||
|
2020
Q3 | $2.15M | Buy |
|
|||||
|
2020
Q2 | $490K | Sell |
|
|||||
|
2020
Q1 | $390K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $779K | Sell |
|
|||||
|
2019
Q1 | $1.19M | Buy |
|
|||||
|
2018
Q4 | $758K | Sell |
|
|||||
|
2018
Q3 | $1.35M | Sell |
|
|||||
|
2018
Q2 | $1.08M | Sell |
|
|||||
|
2018
Q1 | $1.1M | Buy |
|
|||||
|
2017
Q4 | $853K | Buy |
|
|||||
|
2017
Q3 | $556K | Buy |
|
|||||
|
2017
Q2 | $295K | Buy |
|
|||||
|
2017
Q1 | $117K | Sell |
|
|||||
|
2016
Q4 | $161K | Sell |
|
|||||
|
2016
Q3 | $464K | Buy |
|
|||||
|
2016
Q2 | $422K | Sell |
|
|||||
|
2016
Q1 | $397K | Sell |
|
|||||
|
2015
Q4 | $535K | Buy |
|